Home
  >  
Section 10
  >  
Chapter 9,393

Selective inhibitors of monoamine oxidase (MAO) . 5. 1-Substituted phenoxathiin inhibitors containing no nitrogen that inhibit MAO A by binding it to a hydrophobic site

Harfenist, M.; McGee, D.P.; Reeves, M.D.; White, H.L.

Journal of Medicinal Chemistry 41(12): 2118-2125

1998

ISSN/ISBN: 0022-2623
PMID: 9622553
DOI: 10.1021/jm970862j
Accession: 009392551
Download citation:  
Text
  |  
BibTeX
  |  
RIS
It is believed that a monoamine oxidase (MAO) inhibitor specific for MAO A, which is reversibly bound to this enzyme and displaceable by tyramine, will be an antidepressant which will not cause a rise in blood pressure when tyramine-containing foods are ingested.

PDF emailed within 0-6 h: $19.90




Related References

Youdim, M.B. 1976: Monoamine oxidase active site; the binding to and titration of monoamine oxidase with (14C)-selective inhibitors British Journal of Pharmacology 56(3): 375p
Harfenist, M.; Joseph, D.M.; Spence, S.C.; Mcgee, D.P.; Reeves, M.D.; White, H.L. 1997: Selective inhibitors of monoamine oxidase. 4. SAR of tricyclic N-methylcarboxamides and congeners binding at the tricyclics' hydrophilic binding site Journal of Medicinal Chemistry 40(16): 2466-2473
Graham, D.; Tahraoui, L.; Langer, S.Z. 1987: Effect of chronic treatment with selective monoamine oxidase inhibitors and specific 5-hydroxytryptamine uptake inhibitors on [3H]paroxetine binding to cerebral cortical membranes of the rat Neuropharmacology 26(8): 1087-1092
Tzvetkov, N.T.; Stammler, H.-G.; Neumann, B.; Hristova, S.; Antonov, L.; Gastreich, M. 2017: Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors European Journal of Medicinal Chemistry 127: 470-492
Levant, B.; Grigoriadis, D.E.; DeSouza, E.B. 1993: Monoamine oxidase inhibitors inhibit [3H]quinpirole binding in rat striatal membranes European Journal of Pharmacology 246(2): 171-178
Thull, U.; Kneubühler, S.; Testa, B.; Borges, M.F.; Pinto, M.M. 1993: Substituted xanthones as selective and reversible monoamine oxidase A (MAO-A) inhibitors Pharmaceutical Research 10(8): 1187-1190
Levant, B.; Grigoriadis, D.E.; Desouza, E.B. 1993: Monoamine oxidase inhibitors inhibit tritiated quinpirole binding in rat striatal membranes European Journal of Pharmacology Molecular Pharmacology Section 12(2): 171-178
Lebreton, L.; Curet, O.; Gueddari, S.; Mazouz, F.; Bernard, S.; Burstein, C.; Milcent, R. 1995: Selective and potent monoamine oxidase type B inhibitors: 2-substituted 5-aryltetrazole derivatives Journal of Medicinal Chemistry 38(24): 4786-4792
Mattsson, C.; Svensson, P.; Sonesson, C. 2014: A novel series of 6-substituted 3-(pyrrolidin-1-ylmethyl)chromen-2-ones as selective monoamine oxidase (MAO) a inhibitors European Journal of Medicinal Chemistry 73: 177-186
Morikawa, F.; Ueda, T.; Arai, Y.; Kinemuchi, H. 1986: Inhibition of monoamine oxidase A-form and semicarbazide sensitive amine-oxidase by selective and reversible monoamine oxidase-A inhibitors, amiflamine and FLA 788(+) Pharmacology 32(1): 33-45
Morikawa, F.; Ueda, T.; Arai, Y.; Kinemuchi, H. 1986: Inhibition of monoamine oxidase A-form and semicarbazide-sensitive amine oxidase by selective and reversible monoamine oxidase-A inhibitors, amiflamine and FLA 788(+) Pharmacology 32(1): 38-45
Kalgutkar, A.S.; Castagnoli, N. 1995: Selective inhibitors of monoamine oxidase (MAO-A and MAO-B) as probes of its catalytic site and mechanism Medicinal Research Reviews 15(4): 325-388
Veselovskiĭ, A.V.; Ivanov, A.S.; Medvedev, A.E. 1997: Use of selective inhibitors for computer modeling of the monoamine oxidase active site Voprosy Meditsinskoi Khimii 43(6): 527-536
Medvedev, A.E.; Ivanov, A.S.; Veselovsky, A.V. 2000: Selective inhibitors and computer modelling of the active site of monoamine oxidase Neurobiology 8(2): 201-214
Wang, D.; Hong, R-Yuan.; Guo, M.; Liu, Y.; Chen, N.; Li, X.; Kong, D-Xin. 2019: Novel C7-Substituted Coumarins as Selective Monoamine Oxidase Inhibitors: Discovery, Synthesis and Theoretical Simulation Molecules 24(21)
Levant, B.; Moehlenkamp, J.D.; Morgan, K.A.; Leonard, N.L.; Cheng, C.C. 1996: Modulation of [3H]quinpirole binding in brain by monoamine oxidase inhibitors: evidence for a potential novel binding site Journal of Pharmacology and Experimental Therapeutics 278(1): 145-153
Medvedev, A.E.; Ivanov, A.S.; Veselovsky, A.V. 2003: Computer visualisation of the active site of monoamine oxidase-A by means of selective inhibitors Inflammopharmacology 11(2): 135-143
Calligaro, D.; Helton, D. 1989: Interaction between monoamine oxidase inhibitors mao i and fluoxetine compared to non selective uptake inhibitors Society for Neuroscience Abstracts 15(1): 29
Aboukarr, A.; Giudice, M. 2018: Interaction between Monoamine Oxidase B Inhibitors and Selective Serotonin Reuptake Inhibitors Canadian Journal of Hospital Pharmacy 71(3): 196-207
Bernard, S.; Paillat, C.; Oddos, T.; Seman, M.; Milcent, R. 1995: Selective and potent monoamine oxidase type B inhibitors: Substituted semicarbazones and acylhydrazones of aromatic aldehydes and ketones European Journal of Medicinal Chemistry 30(6): 471-482